Key result
Malignant primary cardiac tumors had an 82% mortality rate (median survival 6.0 months), compared to a 72% mortality rate (median survival 3.6 months) for metastatic cardiac tumors.
Why the study?
Malignant primary cardiac tumors are exceedingly rare with poor prognosis despite therapy, and metastatic cardiac invasion also entails an unsatisfactory outcome.
Observational (n=60)
No
Absolute Event Rate: 82% vs 72%
Malignant primary and metastatic cardiac tumors remain exceedingly rare but carry a dismal prognosis, though heart transplantation may offer long-term survival in highly selected patients with primary sarcomas.
No takes yet. Share an insight, caveat, or question.
Anticipate limited survival in either group and prioritize goals-of-care discussions; leaves open whether origin-specific therapy alters outcomes.
Bras et al. (2023) conducted an observational in Malignant primary and metastatic cardiac tumors (n=60). Malignant primary cardiac tumors vs. Metastatic cardiac tumors was evaluated on Mortality rate. Malignant primary cardiac tumors had an 82% mortality rate (median survival 6.0 months), compared to a 72% mortality rate (median survival 3.6 months) for metastatic cardiac tumors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: